Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial [corrected] [published errata appear in CLIN THER 2009 Feb;31(2):446, and Jul;31(7):1617].

Authors
Category Primary study
JournalClinical Therapeutics
Year 2008
This article has no abstract
Epistemonikos ID: fa08fd444c29a5bdaf13ac46d6cd86bde964d753
First added on: Apr 03, 2025